Brief: Caplin Point Laboratories Says Caplin Steriles Gets USFDA Approval For Ketorolac Tromethamine Ophthalmic
28/03/2024 05:40
March 28 (Reuters) - Caplin Point Laboratories Ltd
CAPL.NS :
* CAPLIN STERILES GETS USFDA APPROVAL FOR KETOROLAC
TROMETHAMINE
OPHTHALMIC
* GRANT OF FINAL APPROVAL FROM USFDA FOR ANDA KETOROLAC
TROMETHAMINE OPHTHALMIC SOLUTION 0.5%
Source text for Eikon: ID:nBSE6BLKVV
Further company coverage: CAPL.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Caplin Point Laboratories
See all newsBrief: Caplin Point Laboratories Says US FDA Completes Unannounced Inspection Of Caplin Steriles Gummidipoondi Facility
Brief: Caplin Point Laboratories March-Quarter Consol Net Profit 1.7 Bln Rupees
Brief: Caplin Point Laboratories Unit Receives Final USFDA Approval For ANDA Potassium Phosphates Injection
Brief: Caplin Point Laboratories Says Unit Receives USFDA Approval For Sodium Phosphates Injection
Brief: Caplin Point Laboratories Dec-Quarter Consol Net Profit 1.64 Billion Rupees